PIPages
Labs

Xiongyi Huang

Johns Hopkins University, MD·Chemistry

Building a drug molecule often means adding a new chemical group exactly where you want it. Carbon–hydrogen (C–H) bonds are everywhere in organic molecules, so turning one specific C–H bond into something useful is one of the most direct ways to build or modify a drug candidate.

Fields

Chemistry

Biochemistry

Topics

biocatalysis

metalloenzymes

C-H functionalization

Grants
1 known grant, through Jul 2027

What they work on

  1. Engineer metalloenzymes — proteins with a catalytic metal center — to perform C–H functionalization reactions absent from natural biology, installing chemical groups of biomedical relevance into organic substrates.
  2. Use computational modeling of substrate binding and metal-center reactivity to guide protein engineering, predicting which active-site changes should enable functionalization of strong, unreactive sp3 C–H bonds.
  3. Characterize reaction mechanisms and reactive metal intermediates using biochemical assays together with inorganic spectroscopic methods, to explain how the engineered enzymes activate inert C–H bonds.
  4. Apply organic synthesis to prepare substrate panels and product standards, mapping the reaction scope and selectivity of the resulting enzyme collections for drug synthesis and diversification.

More about the research

Enzymes are attractive catalysts for this job: they are highly selective, work under mild conditions, and their behavior can be tuned by changing their genes. The problem is that enzymes only know the reactions that natural evolution gave them, and many chemical groups that matter in medicine are rare or entirely absent in biology.

Why it matters

Medicinal chemists need practical ways to install specific chemical groups into drug candidates. Enzymes that functionalize ordinary C–H bonds could make drug synthesis and diversification more selective, more sustainable, and able to reach molecules that current small-molecule catalysts cannot. Because these catalysts are encoded in DNA, they could also be improved by engineering rather than redesigned from scratch.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

A Chemo-Mimetic Platform to Reprogram Metalloenzymes for Non-Natural Biocatalytic C-H Functionalization Reactions

NIH · Aug 2022 – Jul 2027

Closest labs

Peng Liu

University of Pittsburgh, PA·Chemistry

Identify the rate- and selectivity-determining transition states of metal-catalyzed alkene functionalization reactions, using density functional theory and ab initio molecular dynamics simulations.

Michel Gagne

University of North Carolina at Chapel Hill, NC·Chemistry

Develop site-selective and functional group-directed C-H functionalization reactions, which convert specific carbon-hydrogen bonds into new groups, using light-activated organic photoredox catalysts.

Joseph M Bollinger

Pennsylvania State University, PA·Biochemistry

Determine how iron(II) and 2-oxoglutarate-dependent (Fe/2OG) oxygenases direct a common oxoiron(IV) intermediate toward hydroxylation, halogenation, desaturation, or cyclization, and test this by rationally redirecting reaction outcomes.

The school

Johns Hopkins University: 100 labs on PI Pages, $4.1B a year on research, 622 research doctorates a year.

More about Johns Hopkins University

Reach out

A start for your email. Fill in the brackets.